Catheter Precision Free Cash Flow (FCF) History (VTAK)
Catheter Precision reported −$8.3M in free cash flow for fiscal 2025, an increase of $1.0M from the previous fiscal year, with a free cash flow margin of −1015.02%.
View full Catheter Precision company overviewCatheter Precision free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$8.3M | $1.0M | — | −1015.02% |
| 2024 | 2024-12-31 | −$9.3M | $11.4M | — | −2223.33% |
| 2023 | 2023-12-31 | −$20.7M | $1.9M | — | −4682.13% |
| 2022 | 2022-12-31 | −$22.6M | $5.3M | — | −161321.43% |
| 2021 | 2021-12-31 | −$27.9M | $481,000 | — | −126772.73% |
| 2020 | 2020-12-31 | −$28.4M | $5.1M | — | −10954.05% |
| 2019 | 2019-12-31 | −$33.4M | −$14.4M | — | −464.52% |
| 2018 | 2018-12-31 | −$19.1M | −$13.0M | — | −305.10% |
| 2017 | 2017-12-31 | −$6.1M | — | — | −103.41% |
Catheter Precision quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$2.9M | −$606,000 | — | −282.24% |
| Q1 2026 | 2026-03-31 | −$2.8M | −$454,000 | — | −648.61% |
| Q4 2025 | 2025-12-31 | −$1.5M | $1.4M | — | −635.29% |
| Q3 2025 | 2025-09-30 | −$2.2M | $585,000 | — | −965.93% |
| Q2 2025 | 2025-06-30 | −$2.3M | −$528,000 | — | −1070.75% |
| Q1 2025 | 2025-03-31 | −$2.3M | −$384,000 | — | −1641.96% |
| Q4 2024 | 2024-12-31 | −$2.9M | −$957,000 | — | −1922.15% |
| Q3 2024 | 2024-09-30 | −$2.8M | −$937,000 | — | −2883.33% |
| Q2 2024 | 2024-06-30 | −$1.7M | $3.1M | — | −1873.12% |
| Q1 2024 | 2024-03-31 | −$2.0M | $10.1M | — | −2395.12% |
| Q4 2023 | 2023-12-31 | −$1.9M | $1.1M | — | −1489.84% |
| Q3 2023 | 2023-09-30 | −$1.8M | $3.1M | — | −1376.69% |
| Q2 2023 | 2023-06-30 | −$4.9M | $1.1M | — | −5069.79% |
| Q1 2023 | 2023-03-31 | −$12.1M | −$3.5M | — | −14223.53% |
| Q4 2022 | 2022-12-31 | −$3.0M | $2.7M | — | — |
| Q3 2022 | 2022-09-30 | −$5.0M | $2.4M | — | −99320.00% |
| Q2 2022 | 2022-06-30 | −$6.0M | $669,000 | — | −120160.00% |
| Q1 2022 | 2022-03-31 | −$8.6M | −$471,000 | — | −95211.11% |
| Q4 2021 | 2021-12-31 | −$5.8M | $3.7M | — | −143800.00% |
| Q3 2021 | 2021-09-30 | −$7.4M | −$1.3M | — | −147260.00% |
| Q2 2021 | 2021-06-30 | −$6.7M | −$856,000 | — | −74188.89% |
| Q1 2021 | 2021-03-31 | −$8.1M | −$1.0M | — | −202450.00% |
| Q4 2020 | 2020-12-31 | −$9.4M | $201,000 | — | — |
| Q3 2020 | 2020-09-30 | −$6.1M | $1.8M | — | −8926.47% |
| Q2 2020 | 2020-06-30 | −$5.8M | $1.0M | — | −646.78% |
| Q1 2020 | 2020-03-31 | −$7.1M | $2.0M | — | −514.63% |
| Q4 2019 | 2019-12-31 | −$9.6M | −$1.1M | — | −692.09% |
| Q3 2019 | 2019-09-30 | −$7.9M | −$3.6M | — | −412.89% |
| Q2 2019 | 2019-06-30 | −$6.8M | −$3.2M | — | −317.42% |
| Q1 2019 | 2019-03-31 | −$9.1M | −$6.6M | — | −521.11% |
| Q4 2018 | 2018-12-31 | −$8.6M | — | — | −430.43% |
| Q3 2018 | 2018-09-30 | −$4.3M | — | — | −209.11% |
| Q2 2018 | 2018-06-30 | −$3.7M | — | — | −297.09% |
| Q1 2018 | 2018-03-31 | −$2.5M | — | — | −262.64% |
Catheter Precision free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$28.4M to −$8.3M, a net increase of $20.1M. Catheter Precision's latest reported quarter, Q2 2026, generated −$2.9M in free cash flow, a decrease of $606,000 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Catheter Precision filings at SEC.gov ↗